DE
Journey Medical Corporation
DERM · NASDAQ
$7.36 -0.41% (-$0.03)
1M +13.93%
Market Cap $195.1M
P/E Ratio -
Div. Yield -
ROE 20.23%
Piotroski F-Score Moderate
4/9Valuation
19 /100
Expensive EV/EBITDA 105.48x
P/S 2.86x
P/B 6.08x
Growth
22 /100
Declining Rev. growth 5.66%
Book val. growth 23.32%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 62.24%
Net margin 8.95%
FCF margin 10.99%
Quality
9 /100
Poor ROIC 5.23%
ROE 20.23%
Asset turnover 0.69x
Debt
66 /100
Moderate Debt/Equity 0.80x
Current ratio 1.59x
Net debt/EBITDA -0.06x
Stability
35 /100
Moderate Beta 1.10x
Rev. volatility 21.95%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na DERM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Claude Maraoui
Employees
58
Headquarters
Scottsdale
Nadcházející události
11 LIS
Earnings
Upcoming earnings report